// App-Quantinova.ai

S4036 2015 AHA : Albuminuria and Outcomes in Patients with Non-ST-segment Elevation Acute Coronary Syndromes: Results From the TRACER Trial

Researchers

Presenter

  • Robert Clare

Principal Investigators

  • Yuliya Lokhnygina

  • Harvey White

  • Philip Aylward

  • SAHMRI

  • Kenneth Mahaffey

  • Pierluigi Tricoci

  • Lars Wallentin

  • Claes Held

  • Frans Van de Werf

  • David Moliterno

  • Uptal Patel

  • Sergio Leonardi

  • Paul Armstrong

  • Robert Harrington

Medical Centers

  • Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC

  • Fondazione IRCCS Policlinico San Matteo, NICU, Pavia, Italy

  • Green Lane Cardiovascular Service, Auckland, New Zealand

  • Univ Hosps Leuven, Leuven, Belgium

  • Duke Clinical Research Institute, Durham, NC

  • Uppsala Univ / Uppsala Clinical Res Ctr, Uppsala, Sweden

  • Univ. of Alberta, Edmonton, Alberta, Canada.

  • Gill Heart Inst and Univ of Kentucky, Lexington, KY

  • Duke Univ Medical Ctr/Duke Clinical Res Inst, Durham, NC

  • Flinders University Medical Centre, Adelaide, Australia

  • Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden

Locations

  • Canada

  • Italy

  • Sweden

  • Australia

  • United States

  • Belgium

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Urology

Disease

  • Acute Coronary Syndromes

  • Chronic kidney disease

  • Myocardial infarction

  • Microalbuminuria

  • Renal disease

  • Hypertension

  • Albuminuria

  • Diabetes

Biomarkers

  • Creatinine

  • Human albumin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved